Partners' Directory

  Home   Search   Join the Partnership   Login

Contact General Specializations in Countries Contribution to the Global Plan Declaration

View this partner's profile

Organization Contact Information

Name: ImmunoBiology Limited
Street 1: Babraham Research Campus
Street 2: Babraham
City: Cambridge
Province: Cambs
Post Code: CB22 3AT
Country: United Kingdom of Great Britain and Northern Ireland
Phone: 44122349611
Email: camilo.colaco@immunobiology.co.uk
Web Site: http://www.immunobiology.co.uk

Focal Point Contact Information

Salutation: Dr
First Name: Camilo
Last Name: Colaco
Title: PhD
Email: camilo.colaco@immunobiology.co.uk
Phone:  

Alternate Focal Point Contact Information

Salutation: Mr
First Name: Clarke
Last Name: Graham
Title: CEO
Email: graham.clarke@immunobiology.co.uk
Phone:  

General Information

Board Constituency: Private sector
Organization Type - Primary: Private Sector
Organization Type - Secondary: Company
Is your organization legally registered in your country: Yes
Organization Reach: International
Organization Description:
Vaccine Research and Development - Developing vaccines against infectious disease targets using proprietary ImmBioVax vaccine technology platform that give multi-subunit vaccines that elicit polyclonal cellular and humoral immunity.
Developing multi-subunit TB vaccine, initially to boost BCG, that can be used in HIV positive people
 
Total number of staff in your organization: 11 - 25
Number of full-time staff who are directly involved with TB: 1 - 5
Number of part-time staff who are directly involved with TB: 1 - 5
Number of volunteers who are directly involved with TB: 0
 
What is your organization's annual budget (USD) dedicated to TB? $100,001-$500,000
How did you hear about the Stop TB Partnership: Involvement in TB control provision
If you were informed or referred by another partner of the Stop TB Partnership please tell us who:
Why do you wish join the Stop TB Partnership: Involvement in Stop TB Working Groups
 
Are you a member of a Stop TB national partnership: No
Are you in contact with your national TB programme: No
Please tell us how your organization is contributing to your country's national TB control plan:
Development of a TB vaccine
 

Geographical Reach

Which country is your headquarters located in: United Kingdom of Great Britain and Northern Ireland
Which WHO region is the main focus of your work: European
Which countries do you do operate in:
(This includes countries you are conducting activities in)
United Kingdom of Great Britain and Northern Ireland

Specializations

Research and Development

Specializations in Countries

Research and Development United Kingdom of Great Britain and Northern Ireland

Contribution

Please tell us how your organization will contribute to the Global Plan to Stop TB by briefly describing its involvement in any of the areas of work listed below:

TB-HIV:
Development of TB vaccine that can be used in HIV positive individuals

New TB Vaccines:
Development of TB vaccine that can be used to boost and replace BCG

Declaration

Declaration of interests:
ImmunoBiology is a vaccine company that is working on the development of prophylactic, booster and therapeutic TB vaccines

Application date:  
Last updated: June 28, 2012